Self-screening of Cognitive Impairment in Primary Care (OCEANE)

Centre Hospitalier Universitaire, Amiens

Status: Withdrawn

Conditions: Alzheimer Disease; Cognition Disorder

Treatments: Other: SAGE (Self-Administered Gerocognitive Exam); Other: MMSE (mini mental state examination)

Study type: Interventional

Funder types: Other

Identifiers

NCT04019665

PI2018_843_0024

Details and patient eligibility

About

According to 2011 HAS recommendations, early detection of Alzheimer disease is the major objective in order to allow an earlier care and support. These recommendations strengthen general practitioner role, who plays a key role in the identification of cognitively impaired patients. HAS recommendations are the use of MMSE like test (Mini Mental State Examination) at general practitioner office. A self-screening test, without medical presence, would allow a self-administered cognitive assessment by the patient. A review of the literature about self-administered cognitive tests has been realized. The Self-Administered Gerocognitive Examination (SAGE) has been chosen. It is a brief, valid and reliable cognitive assessment tool, rated on 22 points, which allows an early detection of cognitive impairment, with a sensitivity close to the MMSE test. Nevertheless, SAGE has never been tested at home without medical supervision. In this study, the investigators will determine if SAGE scores at home correlates with MMSE scores at general practitioner office.

Patients with inclusion criteria will be recruited during the general practitioner consultation and will have a clinical assessment included MMSE and clinical data collection. Then, SAGE will be given to the patient in order to be completed at home without medical supervision and send to the general practitioner.

Sex: All

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects from three Picard general practitioner's practice
• 60 years old or more
• patients who accept to complete the tests
• with ou without cognitive complaint
• patients able to read and write
• affiliated to social security system

Exclusion criteria

• major visual disorders
• legal safeguard
• diagnosis of neuro-cognitive disorder

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

SAGE and MMSE score

Other group

Treatment:

Other: MMSE (mini mental state examination)

Other: SAGE (Self-Administered Gerocognitive Exam)